SI0780390T1 - Crystalline modification of CDCH, process for its preparation and pharmaceutical compositions containing it - Google Patents

Crystalline modification of CDCH, process for its preparation and pharmaceutical compositions containing it

Info

Publication number
SI0780390T1
SI0780390T1 SI9630468T SI9630468T SI0780390T1 SI 0780390 T1 SI0780390 T1 SI 0780390T1 SI 9630468 T SI9630468 T SI 9630468T SI 9630468 T SI9630468 T SI 9630468T SI 0780390 T1 SI0780390 T1 SI 0780390T1
Authority
SI
Slovenia
Prior art keywords
cdch
preparation
pharmaceutical compositions
compositions containing
crystalline modification
Prior art date
Application number
SI9630468T
Other languages
English (en)
Slovenian (sl)
Inventor
Alfons Dr. Grunenberg
Patrick Dr. Bosche
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7779831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI0780390(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of SI0780390T1 publication Critical patent/SI0780390T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI9630468T 1995-12-12 1996-11-29 Crystalline modification of CDCH, process for its preparation and pharmaceutical compositions containing it SI0780390T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19546249A DE19546249A1 (de) 1995-12-12 1995-12-12 Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
EP96119134A EP0780390B1 (de) 1995-12-12 1996-11-29 Kristallmodifikation des CDCH, Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
SI0780390T1 true SI0780390T1 (en) 2002-10-31

Family

ID=7779831

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9630468T SI0780390T1 (en) 1995-12-12 1996-11-29 Crystalline modification of CDCH, process for its preparation and pharmaceutical compositions containing it

Country Status (42)

Country Link
US (1) US5849752A (instruction)
EP (1) EP0780390B1 (instruction)
JP (1) JP4104687B2 (instruction)
KR (1) KR100525146B1 (instruction)
CN (1) CN1061348C (instruction)
AR (1) AR005009A1 (instruction)
AT (1) ATE221531T1 (instruction)
AU (1) AU708006B2 (instruction)
BG (1) BG62258B1 (instruction)
BR (1) BR9605968A (instruction)
CA (1) CA2192418C (instruction)
CO (1) CO4480105A1 (instruction)
CU (1) CU22774A3 (instruction)
CZ (1) CZ288657B6 (instruction)
DE (2) DE19546249A1 (instruction)
DK (1) DK0780390T3 (instruction)
EE (1) EE03474B1 (instruction)
ES (1) ES2179910T3 (instruction)
HR (1) HRP960558B1 (instruction)
HU (1) HU226521B1 (instruction)
ID (1) ID22625A (instruction)
IL (1) IL119795A (instruction)
IN (1) IN185805B (instruction)
MA (1) MA24342A1 (instruction)
MY (1) MY117492A (instruction)
NL (1) NL300109I1 (instruction)
NO (1) NO306725B1 (instruction)
NZ (1) NZ299905A (instruction)
PL (1) PL184885B1 (instruction)
PT (1) PT780390E (instruction)
RO (1) RO119782B1 (instruction)
RU (1) RU2162468C2 (instruction)
SA (1) SA96170492B1 (instruction)
SG (1) SG47201A1 (instruction)
SI (1) SI0780390T1 (instruction)
SK (1) SK282805B6 (instruction)
SV (1) SV1996000109A (instruction)
TR (1) TR199600970A2 (instruction)
TW (1) TW411340B (instruction)
UA (1) UA35638C2 (instruction)
YU (1) YU49485B (instruction)
ZA (1) ZA9610405B (instruction)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1017392T1 (en) * 1997-09-25 2002-12-31 Bayer Aktiengesellschaft Medicament formulation with a controlled release of an active agent
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
WO2000027398A1 (de) 1998-11-10 2000-05-18 Bayer Aktiengesellschaft Pharmazeutische zubereitung von moxifloxacin
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
WO2004039804A1 (en) * 2002-10-31 2004-05-13 Ranbaxy Laboratories Limited Amorphous moxifloxacin hydrochloride
CA2521398C (en) * 2003-04-09 2011-03-22 Dr. Reddy's Laboratories Limited A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for preparation thereof
EP1651630A1 (en) * 2003-08-05 2006-05-03 Matrix Laboratories Ltd An improved process for the preparation of moxifloxacin hydrochloride
ITMI20032259A1 (it) 2003-11-20 2005-05-21 Chemi Spa Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione
WO2005054240A1 (en) * 2003-11-20 2005-06-16 Chemi Spa Polymorphs of 1-cyclopropyl-7-([s,s]-2,8-diazadicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
DE102004015981A1 (de) * 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE102004063347A1 (de) * 2004-12-23 2006-07-13 Stada Arzneimittel Ag Gebrauchsfertige Gemcitabinlösungen und Gemcitabinlösungskonzentrate
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
GB0612422D0 (en) * 2006-06-23 2006-08-02 Generics Uk Ltd Novel hydrate form
SI2032521T1 (sl) 2006-06-27 2010-02-26 Sandoz Ag Nov postopek za pripravo soli
ES2303768B1 (es) * 2006-09-08 2009-06-05 Quimica Sintetica, S.A. Nueva forma cristalina de moxifloxacino clorhidrato.
AU2007320997B2 (en) * 2006-11-13 2012-11-08 Cipla Limited Process for the synthesis of moxifloxacin hydrochloride
EP1992626A1 (en) * 2007-05-10 2008-11-19 Sandoz AG Process for the preparation of moxifloxacin hydrochloride
EP2083010A1 (en) * 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
BRPI0823092A2 (pt) * 2008-10-09 2015-09-29 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi método de granulação úmida de moxifloxacin anídrico ou seus sais
EP2342204A1 (en) * 2008-11-06 2011-07-13 Hetero Research Foundation Novel polymorph of moxifloxacin hydrochloride
ES2467105T5 (es) 2008-12-08 2017-12-05 Ratiopharm Gmbh Moxifloxacino compactado
NZ596492A (en) 2009-05-15 2013-08-30 Redx Pharma Ltd Redox drug derivatives
WO2011121596A2 (en) * 2010-04-01 2011-10-06 Neuland Laboratories Ltd. Crystal modification of moxifloxacin hydrochloride
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN102924449B (zh) * 2012-10-30 2015-08-12 重庆福安药业集团庆余堂制药有限公司 盐酸莫西沙星h晶型及其制备方法和药物组合物
US9388178B2 (en) 2012-12-04 2016-07-12 Mankind Research Centre Process for the preparation of moxifloxacin hydrochloride
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
US12036219B2 (en) 2013-03-15 2024-07-16 Melinta Subsidiary Corp. Methods of treating infections in overweight and obese patients using antibiotics

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
CN1019114B (zh) * 1986-03-31 1992-11-18 三共株式会社 喹啉-3-羟酸衍生物的制备方法
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
RO108347B1 (ro) * 1989-10-30 1994-04-28 Bellon Labor Sa Roger DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA
TW209865B (instruction) 1992-01-10 1993-07-21 Bayer Ag
ES2167329T3 (es) * 1992-01-31 2002-05-16 Chugai Pharmaceutical Co Ltd Cristal de hidrato de derivado de acido quinolonacarboxilico.
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
NO301165B1 (no) * 1992-12-25 1997-09-22 Daiichi Seiyaku Co Bicykliske aminderivater og antibakterielle midler inneholdende disse
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
EP0676199B1 (en) * 1994-04-07 1998-09-02 Pfizer Inc. Use of trovafloxacin or derivatives thereof for the manufacture of a medicament for the treatment of H. pylori infections

Also Published As

Publication number Publication date
MA24342A1 (fr) 1998-07-01
CN1160052A (zh) 1997-09-24
HU9603428D0 (en) 1997-01-28
KR970042550A (ko) 1997-07-24
JPH09169757A (ja) 1997-06-30
SV1996000109A (es) 1997-10-23
NL300109I1 (nl) 2003-02-03
ZA9610405B (en) 1997-06-23
JP4104687B2 (ja) 2008-06-18
NO965298D0 (no) 1996-12-11
PL184885B1 (pl) 2003-01-31
PT780390E (pt) 2002-11-29
SA96170492B1 (ar) 2006-05-23
CU22774A3 (es) 2002-07-24
MX9606325A (es) 1997-10-31
NO965298L (no) 1997-06-13
SG47201A1 (en) 1998-03-20
EP0780390B1 (de) 2002-07-31
EP0780390A1 (de) 1997-06-25
MY117492A (en) 2004-07-31
RO119782B1 (ro) 2005-03-30
AU708006B2 (en) 1999-07-29
EE03474B1 (et) 2001-08-15
TR199600970A2 (tr) 1997-06-21
HRP960558A2 (en) 1998-02-28
HU226521B1 (en) 2009-03-30
RU2162468C2 (ru) 2001-01-27
IL119795A (en) 1998-12-27
YU49485B (sh) 2006-08-17
PL317415A1 (en) 1997-06-23
US5849752A (en) 1998-12-15
KR100525146B1 (ko) 2006-01-27
CZ288657B6 (cs) 2001-08-15
NO306725B1 (no) 1999-12-13
BG101043A (en) 1998-04-30
HUP9603428A2 (en) 1997-08-28
AU7421696A (en) 1997-06-19
SK159196A3 (en) 1997-10-08
YU65096A (sh) 1998-12-23
UA35638C2 (uk) 2001-04-16
NZ299905A (en) 1998-09-24
DE59609501D1 (de) 2002-09-05
DK0780390T3 (da) 2002-11-11
HUP9603428A3 (en) 1997-10-28
HRP960558B1 (en) 2002-04-30
CN1061348C (zh) 2001-01-31
DE19546249A1 (de) 1997-06-19
CO4480105A1 (es) 1997-07-09
EE9600201A (et) 1997-06-16
ATE221531T1 (de) 2002-08-15
IL119795A0 (en) 1997-03-18
CA2192418A1 (en) 1997-06-13
CZ364696A3 (en) 1997-07-16
IN185805B (instruction) 2001-05-05
SK282805B6 (sk) 2002-12-03
BR9605968A (pt) 1998-08-18
AR005009A1 (es) 1999-04-07
TW411340B (en) 2000-11-11
ID22625A (id) 1999-12-02
ES2179910T3 (es) 2003-02-01
BG62258B1 (bg) 1999-06-30
CA2192418C (en) 2001-06-12

Similar Documents

Publication Publication Date Title
SI0780390T1 (en) Crystalline modification of CDCH, process for its preparation and pharmaceutical compositions containing it
IL122118A (en) Crystalline form I atorvastatin pharmaceutical compositions containing it and process for its preparation
SI1156049T1 (en) Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
HUP0001607A3 (en) Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compounds
CZ58196A3 (en) Naphthyl derivative, process of its preparation, pharmaceutical composition containing and intermediate for preparing thereof
IL117598A (en) Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them
ZA969248B (en) New aminoacid derivatives process for the manufacture thereof and pharmaceutical compositions containing thesse compounds
HUP9601033A2 (en) Benzofurane derivatives, process for their preparation, use of them as intermediate and pharmaceutical compositions containing the compounds
CZ129596A3 (en) Oxazolidinone derivative, process of its preparation and pharmaceutical composition containing thereof
HUP9602635A3 (en) 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9901065A3 (en) New barbituric acid derivatives, pharmaceutical compositions containing these compounds and process for producing them
HUP0003053A3 (en) Crystalline forms of 33-epichloro-33-desoxyascomycin, process for their preparation and pharmaceutical compositions containing them
HUP9801993A3 (en) Ascomycin derivatives and their use for preparation of pharmaceutical compositions, process for their preparation and pharmaceutical compositions containing them
CZ346595A3 (en) Substituted derivatives of 4-phenylthiazoles, process of their preparation and pharmaceutical compositions containing thereof
GB9617893D0 (en) New pharmaceutical derivatives, process for obtaining them and pharmaceutical compositions containing them
IL141955A0 (en) Benzothiazolone derivatives, process for their preparation and pharmaceutical compositions containing them
IL117495A0 (en) Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
HUT72319A (en) Epoxy-succinic acid derivatives, pharmaceutical compositions containing them and process for their preparation
AU4878997A (en) Novel isoxazol derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the novel compounds
HU9602640D0 (en) Substituted benzoyl-guanidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9601680A3 (en) Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds
ZA966154B (en) Aminophenylphosphonic acid compounds process for preparing them and pharmaceutical compositions containing them
HUP9801068A3 (en) 1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them
ZA963350B (en) Cycloheaxane compounds process for their preparation and pharmaceutical compositions containing them
HUP9600173A3 (en) 4-amino-benzoyl-guanidine derivatives, process for preparing them and pharmaceutical compositions containing them